503A

Testosterone Nasal Gel

503A

Testosterone Nasal Gel

503A

Testosterone Nasal Gel

5 mg / 0.05 mL10 mg / 0.05 mL

Placeholder

$100.00

Add to cart
Buy Now

Product Overview

This product is available solely through our 503A Compounding Pharmacy, ensuring personalized care and precision in every order. Please note that a valid prescription is required for purchase. If you do not have an account, please contact us.

Testosterone Nasal Gel (3 mL Pen)

5 mg / 0.05 mL10 mg / 0.05 mL

Testicular, ovarian, and adrenal cortical cells generate endogenous testosterone. Chief androgen found in the human body is testosterone. Whether acquired or inherited, the treatment of hypogonadism depends on the use of testosterone. Testosterone is the best external androgen for palliative care in postmenopausal breast cancer sufferers. materials as a result of their historical illegal use. In 1991, along with several anabolic steroids, testosterone was designated as a disallowed drug. Uniumed Pharmaceuticals produced AndroGel, a testosterone cream that got FDA clearance in 2000 to treat hypogonadism, in the US. Lack of testosterone characterizes this condition, which often leads to a variety of symptoms including sexual disorders as well as mood and energy problems. It also helps to treat a variety of injury-related problems including those impacting persons who have endured significant burns or suffered injuries.

The transdermal testosterone gel targets the same, or at least very comparable, body areas as injections and other testosterone formulations. More exactly, maximum absorption of testosterone gel is attained when it is given to densely muscled body areas—as with injectable testosterone. Since more muscle at the site of administration corresponds with a greater number of testosterone absorbing capillaries, testosterone may be more quickly transported into the bloodstream.

Sexual maturity at all phases of life depends on endogenous testosterone. Synthetically, it is made from cholesterol. Starting in the fetus, androgens’ role in male development is vital during puberty and continues to be significant in the adult man.

Through a negative-feedback mechanism, increased androgen plasma concentrations suppress gonadotropin-releasing hormone (hence lowering endogenous testosterone), luteinizing hormone, and folliclestimulating hormone. Additionally influencing erythropoietin synthesis, calcium equilibrium, and blood glucose is testosterone. Androgens have a great lipid solubility, which lets them quickly enter target tissue cells. Testosterone enzymatically transforms to 5alphadihydrotestosterone within the cells and creates a weak complex with cytosolic receptors. Androgen activity results from the commencement of transcription and nuclear cellular modifications triggered by this steroid receptor complex.

Usually, endogenous androgens activate RNA polymerase, hence increasing protein synthesis. Androgens promote a rapid rise in muscular growth and development during puberty, along with shifting of body fat. growth finish puberty. Also controlled by the androgens are the fusing of the epiphyses and the stopping of development as well as the maintenance of spermatogenesis. Normal male growth and development call for use of external androgens when endogenous androgens are lacking.

Safety Considerations and Risks of Testosterone Therapy

Testosterone therapy can be helpful for men with low hormone levels, but it must be used with caution. Certain medical conditions make its use riskier, and careful monitoring is essential.

1. Liver, Kidney, and Heart Conditions

Testosterone may build up in people with liver disease and should be used carefully in these patients.

It can cause fluid retention, which may worsen heart failure, kidney disease, or existing swelling.

There is also concern about a possible link between testosterone use and heart attacks or strokes. Large studies have shown mixed results:

In older men and those with pre-existing heart disease, testosterone therapy was linked to a higher risk of heart attack.

The FDA is still investigating this possible connection and advises doctors to weigh the benefits against potential risks before prescribing.

2. Breathing Issues

Testosterone esters may worsen sleep apnea, especially in men who are obese or have chronic lung problems.

3. Blood Changes

High doses may cause polycythemia (too many red blood cells), which increases the risk of blood clots. Regular blood tests to check hemoglobin and hematocrit are recommended.

4. Pregnancy and Women

It is not recommended for women in general use, as it may cause unwanted male-like effects such as deepening of the voice, acne, or excess hair growth.

In women with certain cancers, testosterone may sometimes be prescribed, but close monitoring is needed.

If a female partner or child touches the application site, it can lead to elevated testosterone in their bodies, causing problems like genital changes, early puberty, or aggressive behavior in children. To prevent this:

Men should wash hands after applying gel,

Cover the application site with clothing, and

Wash the area before skin-to-skin contact.

5. Breastfeeding

Testosterone should not be used during breastfeeding. It may pass into breast milk and cause androgenic effects in infants, or interfere with milk production.

6. Diabetes and Calcium Levels

It can also worsen high calcium levels, especially in men with metastatic breast cancer.

7. Injection-Specific Risks

Symptoms include cough, chest pain, dizziness, or fainting.

Because of these risks, Aveed is only available through a special safety program (REMS) where clinics are equipped for emergency treatment.

8. Nasal Formulations

Nasal testosterone should be avoided in people with nasal disorders or recent surgery, as absorption may be reduced.

Conditions like allergic rhinitis (runny or congested nose) can lower how much of the drug is absorbed, making it less effective.

9. Children and Teenagers

Accidental exposure in children to testosterone gels has caused genital changes, early puberty, and aggressive behavior.

Important Information About Testosterone and Drug Interactions
If you’re using testosterone therapy, it’s important to know that it can interact with certain medicines and affect how they work. Always tell your healthcare provider about all the medications, supplements, and herbs you take, as well as if you smoke, drink alcohol, or use recreational drugs. This helps avoid unwanted interactions.

Common Medicines That May Interact with Testosterone
Diabetes medications: Testosterone can affect blood sugar control, so your doctor may need to adjust your diabetes medicines.
Blood thinners (like warfarin): Testosterone can increase the blood-thinning effect of warfarin, which may raise the risk of serious bleeding. If you’re on warfarin, your doctor will monitor your blood clotting closely and may adjust your dose.
Oxyphenbutazone: Taking this with testosterone may increase oxyphenbutazone levels, so your doctor will watch for side effects.
Propranolol: Testosterone might reduce how well propranolol works, so your doctor may need to adjust your treatment.
Steroid medicines (like prednisone or cortisone): Using these with testosterone can increase the risk of swelling due to fluid retention, especially if you have heart or liver problems.
How Testosterone Is Processed in the Body
Some medicines can affect this enzyme and change testosterone levels in your body:

CYP3A4 inhibitors (like fluconazole and voriconazole): These medicines can increase testosterone levels by slowing its breakdown. The clinical impact isn’t fully clear, but your doctor will monitor you.
P-glycoprotein (P-gp): Testosterone can affect this protein, which helps move drugs in and out of cells.
Other Important Interactions
Cyclosporine: Androgens like testosterone may increase cyclosporine levels, raising the risk of kidney damage.
Corticosteroids: Combining these with testosterone can increase swelling, especially with steroids that cause salt and water retention.
Goserelin and leuprolide: These drugs lower hormone production, so using them with testosterone cancels out their effects and is generally not recommended.
Hepatotoxic drugs: Testosterone can increase the risk of liver damage when taken with other liver-toxic medicines. Your doctor will monitor your liver function.
Human growth hormone: Testosterone may help growth hormone work better, but too much testosterone in young boys can cause bones to mature too fast.
If you’re also taking epoetin alfa (used to treat anemia), testosterone can increase its effect, which might thicken your blood and increase risks.
Herbal Supplements and Testosterone
Saw palmetto (Serenoa repens): This herbal supplement has antiandrogen effects, meaning it can block testosterone’s actions. Using it while on testosterone therapy may reduce the treatment’s effectiveness.
Effects on Blood Sugar and Diabetes
Low testosterone levels are linked to insulin resistance.
Giving testosterone to men with low levels often improves blood sugar control, lowering fasting glucose and HbA1c (a measure of long-term blood sugar).
However, some studies show no effect, and very high doses of anabolic steroids can worsen blood sugar control.
If you have diabetes and are on testosterone, your blood sugar should be monitored closely, as doses of diabetes medicines may need adjustment.
Other Drug Interactions to Know
5-alpha reductase inhibitors (like finasteride and dutasteride): These drugs block testosterone’s effects and are not usually used together with testosterone therapy.
Conivaptan: This drug blocks CYP3A4 and may increase testosterone levels, but the clinical significance is unclear.
Ranolazine: Since testosterone affects P-glycoprotein and CYP3A4, it may increase ranolazine levels, so your doctor will monitor for side effects.
Ambrisentan: Testosterone may increase ambrisentan absorption, so close monitoring is needed if taken together.
Dabigatran: Testosterone can increase dabigatran levels, raising bleeding risk, especially in patients with kidney problems. Avoid this combination if you have severe kidney impairment.
Afatinib: Testosterone may increase afatinib levels.
Intranasal testosterone and other nasal drugs: Using nasal testosterone with other nasal medications is not recommended because interactions are unknown.
Nasal Allergies and Testosterone Absorption
Men with nasal allergies or congestion may absorb less testosterone from nasal sprays.
If you have a cold, allergies, or sinus infection, it’s best to wait until symptoms improve before using nasal testosterone.
Using nasal decongestants like oxymetazoline does not affect testosterone absorption.

Possible Side Effects of Testosterone Therapy
Feminization in Men:
Some men on long-term testosterone therapy may develop breast tenderness or enlargement (gynecomastia). This happens because testosterone can convert into estrogen in the body, especially in men with liver problems. These effects are usually reversible if treatment is stopped.

Effects on Fertility:
High doses of testosterone can reduce sperm production by interfering with hormones that control the testicles. This may lower fertility during treatment.

Sexual Effects:
Some men may experience unwanted prolonged erections (priapism), especially older men or those on high doses.

Prostate Health:
Testosterone therapy can cause the prostate gland to enlarge (benign prostatic hyperplasia or BPH), which may lead to urinary symptoms like frequent urination, urgency, or weak stream. Increases in prostate-specific antigen (PSA) levels have also been observed, which requires monitoring because PSA can be a marker for prostate cancer. Men on testosterone should have regular prostate check-ups.

Effects in Women:
Women exposed to testosterone may develop male characteristics such as acne, excess facial or body hair, deepening of the voice, and menstrual irregularities. These effects may reverse if treatment is stopped early but can become permanent with prolonged use. Pregnant women should avoid testosterone exposure as it can harm the fetus.

Skin Reactions
Testosterone patches and gels can cause skin irritation, redness, itching, blistering, or rash at the application site.
These reactions are usually mild but can sometimes cause patients to stop treatment.
Using mild steroid creams like hydrocortisone on the irritated skin may help.
Avoid placing patches on bony areas or places that get pressure during sleep or sitting to reduce skin problems.
Other Common Side Effects
Acne and oily skin are common because testosterone increases oil gland activity.
Hair loss similar to male pattern baldness can occur with long-term or high-dose use.
Some patients report excessive sweating (hyperhidrosis).
Testosterone buccal tablets (applied inside the mouth) may cause gum irritation, tenderness, or a bitter taste, usually resolving within days.
Bone and Growth Effects
In boys who haven’t reached puberty, testosterone can speed up bone growth but may cause early closure of growth plates, potentially limiting adult height.
Regular bone monitoring is important during treatment in young patients.
Fluid Retention and Blood Pressure
This is more concerning in people with kidney, liver, or heart problems.
Testosterone may also affect blood pressure, sometimes causing hypertension (high blood pressure).
Cardiovascular Risks
Some studies suggest testosterone therapy might increase the risk of serious heart problems like heart attacks or strokes, especially in older men or those with existing heart disease.
The FDA is still reviewing this and has not made a final conclusion.
Doctors carefully weigh the benefits and risks before prescribing testosterone, especially for patients with heart conditions.
Liver Effects
Testosterone can affect liver function, especially certain types of synthetic androgens or when abused at high doses.
Mood and Nervous System
Some patients report headaches, mood swings, anxiety, depression, irritability, or sleep problems like insomnia.
These effects vary and should be discussed with your doctor if they occur.
Gastrointestinal and Other Effects
Diarrhea, vomiting, back pain, chills, and fatigue have been reported in some patients.
Other rare effects include dizziness, increased tear production, and muscle pain.
Blood and Clotting
This can cause symptoms like dizziness, headaches, or unusual bleeding.
Regular blood tests to check red blood cell levels are important.
Testosterone may also increase bleeding risk in patients on blood thinners.
Injection Site Reactions and Serious Allergic Responses
Rarely, serious allergic reactions or lung problems (pulmonary oil microembolism) can occur after certain testosterone injections.
Patients receiving these injections should be monitored closely for at least 30 minutes afterward.
Respiratory and Nasal Effects
Testosterone may worsen sleep apnea, especially in people who are overweight or have lung disease.
If you have nasal allergies or infections, nasal testosterone may be less effective.
When to Seek Medical Help
Call your healthcare provider immediately if you experience:
Severe headache, vision changes, or mood changes
Persistent urinary problems or blood in urine

Because of possible negative consequences on the fetus (FDA pregnancy risk category X), testosterone is contraindicated during pregnancy. Because testosterone is not used during pregnancy, there should be no particular reason to give the products to women during labor or obstetric delivery; safety Efficacy in these circumstances has not been shown either.

In nursing women, testosterone topical solution, transdermal patches, and gels are not advised. Other testosterone products should also be eschewed while nursing. The route of testosterone transfer into breast milk is unknown; it is unknown if exposure would elevate above levels often seen in human milk. Significant exposure to this androgen via breastfeeding may negatively affect the infant and the medication may also obstruct the development of lactation in the mother. Women who are breastfeeding and testosterone therapy should consider other ways.

Store this medication in its original container at 68°F to 77°F (20°C to 25°C) and away from heat, moisture and light. Keep all medicine out of the reach of children. Throw away any unused medicine after the beyond use date. Do not flush unused medications or pour down a sink or drain.

  1. DELATESTRYL (Testosterone Enanthate Injection, USP) package insert. Lexington, MA: Indevus Pharmaceuticals, Inc.; 2007 July.
  2. Axiron (testosterone) topical solution, package insert. Indianapolis, IN: Lilly USA, LLC; 2011 Dec.
  3. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012;60:616-31.
  4. Vigen R, O’Donnell CI, Baron AE, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA. 2013;310:1829-1836.
  5. WD Finkle, S Greenland, GK Ridgeway, et al. Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men. DOI: 10.1371/journal.pone.0085805
  6. FDA Medwatch – FDA evaluating risk of stroke, heart attack and death with FDA-approved testosterone products. Retrieved January 31, 2014. Available on the World Wide Web https://www.fda.gov/Drugs/DrugSafety/ucm383904.htm– LinkOpens in New Tab
  7. (testosterone gel) package insert. Malvern, PA: Auxilium Pharmaceuticals, Inc.; 2010 Apr.
  8. Androderm (testosterone transdermal system) package insert. Corona, CA: Watson Pharma, Inc.; 2014 Jun.
  9. Androgel (testosterone gel) package insert. Marietta, GA: Solvay Pharmaceuticals, Inc.; 2012 Sept.
  10. Striant (testosterone buccal system) package insert. Livingston, NJ: Columbia Laboratories, Inc.; 2014 Mar.
  11. Fortesta (testosterone) gel, package insert. Chadds Ford, PA: Endo Pharmaceuticals Inc.; 2010 Dec.
  12. Aveed (testosterone undecanoate Injection) package insert. Malvern, PA: Endo Pharmaceuticals Solutions Inc.; 2014 Mar.
  13. DEPO-TESTOSTERONE (testosterone cypionate) injection, package insert. New York, NY: Pharmacia & Upjohn Co.; 2006 Sept.
  14. Kochenour NK. Lactation suppression. Clin Obstet Gynecol. 1980;23:1045-1059.
  15. Testim (testosterone gel) package insert. Malvern, PA: Auxilium Pharmaceuticals, Inc.; 2010 Apr.
  16. Krauser JA, Guengerich FP. Cytochrome P450 3A4-catalyzed testosterone 6beta-hydroxylation stereochemistry, kinetic deuterium isotope effects, and rate-limiting steps. J Biol Chem 2005;280:19496—506.
  17. Barnes KM, Dickstein B, Cutler GB Jr, et al. Steroid transport, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells. Biochemistry 1996;35:4820—7.
  18. Wells PS, Holbrook AM, Crowther NR et al. Interaction of warfarin with drugs and food. Ann Intern Med 1994;121:676—83.
  19. Goffin E, Pirson Y, Geubel A, et al. Cyclosporine-methyltestosterone interaction. Nephron 1991;59:174—5.
  20. Borras-Blasco J, Rosique-Robles JD, Peris-Marti J, et al. Possible cyclosporin-danazol interaction in a patient with aplastic anaemia. Am J Hematol 1999;62:63—4.
  21. Moller BB, Ekelund B. Toxicity of cyclosporine during treatment with androgens. N Engl J Med 1985;313:1416.
  22. Ross WB, Roberts D, Griffin PJ, et al. Cyclosporin interaction with danazol and norethisterone. Lancet 1986;1:330.
  23. Androgel® (testosterone gel) package insert. Montrogue, France: Laboratories Besins International; 2005 Aug.
  24. Zoladex® (goserelin acetate) package insert. Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2003 Dec.
  25. Viadur® (leuprolide implant) package insert. Westhaven, CT: Bayer Pharmaceuticals; 2002 May.
  26. Humatrope™ (somatropin);package insert. Indianapolis, IN: Eli Lilly and Company; 2003 Jul.
  27. Androderm® (testosterone transdermal system) package insert. Corona, CA: Watson Pharma, Inc.; 1999 Jan.
  28. Propecia® (finasteride) package insert. Whitehouse Station, NJ: Merck & Co., INC.; 2003 Oct.
  29. Avodart™ (dutasteride) package insert. Research Triangle Park, NC: GlaxoSmithKline; 2005 May.
  30. Robbers JE, Tyler VE. Tyler’s Herbs of Choice: the Therapeutic Use of Phytomedicinals. Binghamton NY: Haworth Herbal Press, Inc.; 1999.
  31. German Commission E. Saw Palmetto berry, Sabal fructus, monograph Published March 2, 1989 and revised January 17, 1991. In: Blumenthal, M et al ., eds. The complete German Commission E Monographs -Therapeutic Guide to Alternative Medicines. Bosto
  32. Lazar JD, Wilner KD. Drug interactions with fluconazole. Rev Infect Dis 1990;12:S327—33.
  33. Hansten P, Horn J. The Top 100 Drug Interactions: A Guide to Patient Management. includes table of CYP450 and drug transporter substrates and modifiers (appendices). H & H Publications, LLP 2014 edition.
  34. Boyanov MA, Boneva Z, Christov VG. Testosterone supplementation in men with type 2 diabetes, visceral obesity, and partial androgen deficiency. Aging Male 2003;6:1—7.
  35. Kapoor D, Goodwin E, Channer KS, et al. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity, and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Clin Endocrinol 2006; 154:899—90
  36. Hobbs CJ, Jones RE, Plymate SR. Nandrolone, a 19-nortestosterone, enhances insulin-independent glucose uptake in normal men. J Clin Endocrinol Metab 1996; 81:1582—5.
  37. Corrales JJ, Burgo RM, Garcia-Berrocal B, et al. Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control. Metabolism 2004;53:666—72
  38. Lee CH, Kuo SW, Hung YJ, et al. The effect of testosterone supplement on insulin sensitivity, glucose effectiveness, and acute insulin response after glucose load in male type 2 diabetics. Endocrine Res 2005;31:139—148.
  39. Cohen JC, Hickman R. Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids. J Clin Endocrinol Metab 1987;64:960—3.
  40. Aldercreutz H, Mazur W. Phyto-estrogens and western diseases. Annals of Medicine 1997;29:95—120.
  41. Ranexa (ranolazine extended-release tablets) package insert. Foster City, CA: Gilead Sciences, Inc. 2013 Dec.
  42. Letairis™ (ambrisentan) package insert. Foster City, CA: Gilead Sciences, Inc; 2008 Oct.
  43. Pradaxa (dabigatran) package insert. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc.; 2015 Jan.
  44. Gilotrif (afatinib) package insert. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc; 2013 Nov.
  45. Androgel 1.62% (testosterone gel) package insert. North Chicago, IL: Abbott Laboratories; 2014 Nov.
  46. Naik BS, Shetty N, Maben EVS. Drug-induced taste disorders. European Journal of Internal Medicine 2010; 21:240-243.

Related medications

503A vs 503B

  • 503A pharmacies compound products for specific patients whose prescriptions are sent by their healthcare provider.
  • 503B outsourcing facilities compound products on a larger scale (bulk amounts) for healthcare providers to have on hand and administer to patients in their offices.

Frequently asked questions

Our team of experts has the answers you're looking for.

A clinical pharmacist cannot recommend a specific doctor. Because we are licensed in Arizona, California, New Mexico, Texas, we can accept prescriptions from many licensed prescribers if the prescription is written within their scope of practice and with a valid patient-practitioner relationship.

*Licensing is subject to change.

Each injectable IV product will have the osmolarity listed on the label located on the vial.

Given the vastness and uniqueness of individualized compounded formulations, it is impossible to list every potential compound we offer. To inquire if we currently carry or can compound your prescription, please fill out the form located on our Contact page or call us at (806) 744-8477.

We source all our medications and active pharmaceutical ingredients from FDA-registered suppliers and manufacturers.

We're licensed to ship Arizona, California, New Mexico and Texas.

We ship orders directly to you, quickly and discreetly.

Ready to get started?